Luye Pharma Group Ltd Cash Flow-to-Debt Ratio
Luye Pharma Group Ltd cash flow-to-debt ratio. Luye Pharma Group Ltd (LUP) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2023, meaning its operating cash flow of €344.86 Million could theoretically repay 0% of its total liabilities (€14.11 Billion) in one year. Check cash flow quality index of Luye Pharma Group Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Luye Pharma Group Ltd (2016–2025)
Cash flow-to-debt ratio of Luye Pharma Group Ltd from 2016 to 2025. Historical debt coverage capacity for Luye Pharma Group Ltd across 10 annual periods. Check LUP total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Luye Pharma Group Ltd Cash Flow-to-Debt Ratio by Year (2016–2025)
Luye Pharma Group Ltd cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Luye Pharma Group Ltd. For the full cash flow conversion analysis, see LUP cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | €1.78 Billion | €14.47 Billion | ▲ +918.2% |
| 2024 | 0.01x | €167.76 Million | €13.86 Billion | ▼ -90.9% |
| 2023 | 0.13x | €1.60 Billion | €11.96 Billion | ▲ +6.5% |
| 2022 | 0.13x | €1.65 Billion | €13.21 Billion | ▲ +824.7% |
| 2021 | 0.01x | €182.37 Million | €13.47 Billion | ▼ -83.6% |
| 2020 | 0.08x | €1.03 Billion | €12.53 Billion | ▼ -42.4% |
| 2019 | 0.14x | €1.42 Billion | €9.94 Billion | ▲ +31.4% |
| 2018 | 0.11x | €1.05 Billion | €9.60 Billion | ▼ -56.4% |
| 2017 | 0.25x | €964.10 Million | €3.86 Billion | ▲ +11.4% |
| 2016 | 0.22x | €592.03 Million | €2.64 Billion | — |